A randomized Phase 2 trial assessing the safety and efficacy of omidenepag isopropyl 0.002% once and twice daily in subjects with primary open-angle glaucoma or ocular hypertension (Spectrum 6)

被引：0

作者：

Olander, Kenneth ^{[1
]}

Sato, Michelle A. ^{[2
]}

Abrams, Marc A. ^{[3
]}

Jerkins, Gary W. ^{[4
]}

Lu, Fenghe ^{[5
]}

Dinh, Phillip ^{[5
]}

Odani, Noriko ^{[5
,6
]}

Chabi, Almira ^{[5
]}

Shams, Naveed Kamal ^{[5
,6
]}

机构：

[1] Univ Eye Specialists, Maryville, TN USA

[2] East West Eye Inst, Torrance, CA USA

[3] Abrams Eye Ctr, Cleveland, OH USA

[4] Adv Vis Res, Nashville, TN USA

[5] Santen Inc, Emeryville, CA USA

[6] Santen Pharmaceut Co Ltd, Osaka, Japan

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2020年 / 61卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

4258

引用

页数：3

共 50 条

[21] Comparison of the IOP-lowering efficacy and safety of the docosanoid unoprostone isopropyl 0.15% versus timolol maleate 0.5% dosed twice daily for 6 months in patients with primary open-angle glaucoma or ocular hypertension.
Stewart, WC
Mundorf, T
Haque, R
Brown, A
Kapik, B
Shams, N
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S557 - S557
[22] A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
Myers, Jonathan S.
Sall, Kenneth N.
DuBiner, Harvey
Slomowitz, Natanya
McVicar, William
Rich, Cadmus C.
Baumgartner, Rudolf A.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (08) : 555 - 562
[23] The use of latanoprost 0.005% once daily to simplify medical therapy in patients with primary open-angle glaucoma or ocular hypertension
Smith, SL
Pruitt, CA
Sine, CS
Hudgins, AC
Stewart, WC
ACTA OPHTHALMOLOGICA SCANDINAVICA, 1999, 77 (02): : 189 - 192
[24] Latanoprost versus timolol gel-forming solution once daily in primary open-angle glaucoma or ocular hypertension
Harasymowycz, Paul
Hutnik, Cindy M. L.
Nicolela, Marcelo
Stewart, William C.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2007, 42 (01): : 75 - 81
[25] Randomized Clinical Trial of the Efficacy and Safety of Preservative-free Tafluprost and Timolol in Patients With Open-Angle Glaucoma or Ocular Hypertension
Chabi, Almira
Varma, Rohit
Tsai, James C.
Lupinacci, Robert
Pigeon, Joseph
Baranak, Christine
Noble, Liliane
Lines, Christopher
Ho, Tony W.
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (06) : 1187 - 1196
[26] Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension
Goldberg, I
Cunha-Vaz, J
Jakobsen, JE
Nordmann, JP
Trost, E
Sullivan, EK
JOURNAL OF GLAUCOMA, 2001, 10 (05) : 414 - 422
[27] A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma
Peace, James H.
McKee, Hayley J.
Kopczynski, Casey C.
OPHTHALMOLOGY AND THERAPY, 2021, 10 (01) : 89 - 100
[28] A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma
James H. Peace
Hayley J. McKee
Casey C. Kopczynski
Ophthalmology and Therapy, 2021, 10 : 89 - 100
[29] Efficacy and safety of latanoprost/timolol fixed combination dosed twice daily compared to once daily in patients with primary open angle glaucoma
Anis Baidura Azal
Siti Husna Hussein
Seng Fai Tang
Othmaliza Othman
Norshamsiah Md Din
International Journal of Ophthalmology, 2023, (08) : 1243 - 1249
[30] Efficacy and safety of latanoprost/timolol fixed combination dosed twice daily compared to once daily in patients with primary open angle glaucoma
Azal, Anis Baidura
Hussein, Siti Husna
Tang, Seng Fai
Othman, Othmaliza
Din, Norshamsiah Md
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2023, 16 (08) : 1243 - 1249

← 1 2 3 4 5 →